Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 6 14-6, 1996, Pages

  Uchiba, Mitsuhiro ^a   Okajima, Kenji ^a   Murakami, Kazunori ^a   Okabe, Hiroaki ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

activated leukocytes; acute respiratory distress syndrome; cytokines; disseminated intravascular coagulation; gram negative septicemia

Indexed keywords

ANTITHROMBIN III; CHLORMETHINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HEPARIN; PROSTACYCLIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG BLOOD VESSEL; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029781690     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.6.l921     Document Type: Article

References (48)

1. 2) in chloralose anesthetized dogs. Br. J. Pharmacol. 61: 136-141, 1977.
2. Bachofen, M., and E. F. Weibel. Structural alterations of lung parenchyma in adult respiratory distress syndrome. Clin. Chest. Med. 3: 35-56, 1982.
3. Bajaj, S. P., S. I. Rapaport, and C. A. Prodanos. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep. Biochem. 11: 397-412, 1981.
4. Bevilacqua, M. P., J. S. Pober, D. L. Mendrick, R. S. Cotan, and M. A. Gimbrone. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84: 9238-9242, 1987.
5. Bone, R. C., R. Balk, G. Slotman, R. Maunder, H. Silverman, T. M. Hyers, and M. D. Kerstein. Adult respiratory distress syndrome. Chest 101: 320-326, 1992.
6. Bone, R. C., R. Maunder, G. Slotman, H. Silverman, T. M. Hyers, M. D. Kerstein, J. J. Ursprung, and the Prostaglandin E1 Study Group. An early test of survival in patients with the adult respiratory distress syndrome. Chest 96: 849-851, 1989.
7. Bruce, N., D. Naime, and O. Edward. The antiinflammatory mechanism of methotrexate. J. Clin. Invest. 92: 2675-2682, 1993.
8. Buller, H. R., and J. W. ten Cate. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications and treatment with antithrombin III concentrate. Am. J. Med. 87 Suppl. 3B: 44S-48S, 1989.
9. Chang, J. C., and M. Lesser. Quantitation of leukocytes in bronchoalveolar lavage samples from rats after intravascular injection of endotoxin. Am. Rev. Respir. Dis. 129: 72-75, 1984.
10. Chang, S. W. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. J. Lab. Clin. Med. 123: 65-72, 1994.
11. Chang, S. W., N. Ohara, G. Kuo, and N. F. Voelkel. Tumor necrosis factor-α induced lung injury is not mediated by platelet-activating factor. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L232-L239, 1989.
12. Coalson, J. J., B. Benjamin, L. T. Archer, B. Beller, C. L. Gilliam, F. B. Taylor, and L. B. Hinshaw. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ. Shock 5: 423-437, 1978.
13. Dickneite, G., and E. P. Pâques. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Thromb. Haemostas. 69: 98-102, 1993.
14. Eisenhut, T., B. Sinha, E. Grottrup-Wolfers, J. Semmler, W. Siess, and S. Endres. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-α in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmacology 26: 259-264, 1993.
15. Emerson, T. E., Jr., M. A. Fournel, T. B. Redens, and F. B. Taylor, Jr. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. Am. J. Med. 87 Suppl. 3B: 27S-33S, 1989.
16. Endo, H., T. Akahoshi, and S. Kashiwazaki. Additive effects of IL-1 and TNF on induction of prostacyclin synthesis in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 156: 1007-1014, 1988.
17. Fourrier, F., C. Chopin, J. Goudemand, S. Hendrycx, C. Caron, A. Rime, A. Marey, and P. Lestavel. Septic shock, multiple organ failure and disseminated intravascular coagulation. Chest 101: 816-823, 1992.
18. Heflin, A. J., and K. L. Brigham. Prevention by granulocyte depletion of increased pulmonary vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68: 1253-1260, 1981.
19. Horie, S., H. Ishii, and M. Kazama. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb. Res. 59: 895-904, 1990.
20. Idell, S., K. K. James, E. G. Levin, B. C. Schwartz, N. Manchanda, R. J. Maunder, T. Martin, J. McLarty, and D. S. Fair. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84: 695-705, 1989.
21. Kainoh, M., R. Imai, T. Umetsu, M. Hattori, and S. Nishio. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem. Pharmacol. 39: 477-484, 1990.
22. Kaplan, K. L., T. Mather, L. DeMarco, and S. Solomon. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Arteriosclerosis 9: 43-49, 1989.
23. Karp, G. I., J. A Marcum, and R. D. Rosenberg. The role of tryptophan residues in heparin-antithrombin interactions. Arch. Biochim. Biophys. 233: 712-720, 1984.
24. Kawabata, K., M. Suzuki, M. Sugitani, K. Imaki, M. Toda, and T. Miyamoto. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biopkys. Res. Commun. 177: 814-820, 1991.
25. Klebanoff, S. J., M. A. Vadas, J. H. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, and A. M. Waltersdorph. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136: 4220-4225, 1986.
26. Maria Riva, C., M. L. Morganroth, A. G. Ljungman, S. O. Schoeneich, R. M. Marks, R. F. Todd III, P. A. Ward, and L. A. Boxer. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am. J. Respir. Cell Mol. Biol. 3: 301-309, 1990.
27. Meyrick, B., L. C. Berry, Jr., and B. W. Christman. Response of cultured human pulmonary artery endothelial cells to endotoxin. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L239-L244, 1995.
28. Miller-Anderson, M., H. Borg, and L. O. Anderson. Purification of antithrombin III by affinity chromatography. Thromb. Res. 5: 439-452, 1974.
29. Morita, T., and C. M. Jackson. Localization of the structural difference between bovine blood coagulation factor X1 and X2 to tyrosine 18 in the activation peptide. J. Biol. Chem. 261: 4008-4014, 1986.
30. Mulligan, M. S., J. Valani, M. K. Dame, C. L. Lane, W. Smith, D. C. Anderson, and P. A. Ward. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J. Clin. Invest. 88: 1396-1406, 1991.
31. Nesheim, M., C. Kettner, E. Shaw, and K. Mann. Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J. Biol. Chem. 256: 6537-6540, 1981.
32. Okajima, K., H. Abe, S. Maeda, M. Motomura, M. Tsujihata, M. Nagataki, H. Okabe, and K. Takatsuki. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Blood 81: 1300-1305, 1993.
33. Okajima, K., H. Ueyama, Y. Hashimoto, Y. Sasaki, K. Matsumoto, H. Okabe, S. Araki, and K. Takatsuki. Homozygous variant of antithrombin III that lacks affinity for heparin: AT III Kumamoto. Thromb. Haemostasis 61: 20-24, 1989.
34. Parrillo, J. E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477, 1993.
35. Rinaldo, J. E., J. H. Dauber, J. Christman, and R. M. Rogers. Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hypoxia. Am. Rev. Respir. Dis. 133: 1065-1071, 1984.
36. Rosenberg, R. D. Biochemistry of heparin antithrombin interactions, and the physiological role of this natural anticoagulant mechanism. Am. J. Med. 87 Suppl. 3B: 2S-9S, 1989.
37. Rubli, E., S. Bussard, and E. Frei. Plasma fibronectin and associated variables in surgical care patients. Ann. Surg. 197: 310-316, 1983.
38. St. John, R. C., and P. M. Dorinsky. Immunologic therapy for ARDS, septic shock, and multiple organ failure. Chest 103: 932-943, 1993.
39. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. The cardiovascular response of normal human to the administration of endotoxin. N. Engl. J. Med. 321: 280-287, 1989.
40. Tateson, J. E., S. Moncada, and J. R. Vane. Effects of prostacyclin (PGx) on cyclic AMP concentration in human platelets. Prostaglandins 13: 389-397, 1977.
41. Triantaphyllopoulos, D. C. Effect of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb. Haemostasis 51: 232-235, 1984.
42. Villa, S., G. de Gaetano, and N. Semeraro. Increased vascular prostacyclin activity in rats after endotoxin administration. Experientia 37: 494-495, 1981.
43. Walker, R. I., L. C. Casey, P. W. Ramwell, and J. R. Fletcher. Association of prostacyclin production with resistance of C3H/HeJ mice to endotoxin shock. Adv. Shock Res. 7: 125-132, 1982.
44. Wallace, J. L., C. M. Keenan, and D. N. Granger. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G463-G467, 1990.
45. Wedmore, C. V., and Williams, T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature Lond. 289: 646-650, 1981.
46. Windsor, A. C. J., P. G. Mullen, A. A. Fowler, and H. J. Sugerman. Role of the neutrophil on adult respiratory distress syndrome. Br. J. Surg. 80: 10-17, 1993.
47. Yamauchi, T., F. Umeda, T. Inoguchi, and H. Nawata. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem. Biophys. Res. Commun. 163: 1404-1411, 1989.
48. Zhang, X., and E. F. Ellis. Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H497-H503, 1990.